{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:17:50Z","timestamp":1791173870489,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T00:00:00Z","timestamp":1261008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s00259-009-1314-7","type":"journal-article","created":{"date-parts":[[2009,12,16]],"date-time":"2009-12-16T05:59:44Z","timestamp":1260943184000},"page":"934-941","source":"Crossref","is-referenced-by-count":34,"title":["In vivo detection of prion amyloid plaques using [11C]BF-227 PET"],"prefix":"10.1007","volume":"37","author":[{"given":"Nobuyuki","family":"Okamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusei","family":"Shiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Furumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsutoshi","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Yanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukitsuka","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Itoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Doh-ura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,17]]},"reference":[{"key":"1314_CR1","unstructured":"DeArmond SJ, Kretzschmar HA, Prusiner SB. Prion diseases. In: Graham DI, Lantos PL, editors. Greenfield\u2019s neuropathology, 7th ed. London: Hodder Arnold. p. 273\u2013323."},{"key":"1314_CR2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(03)15171-9","volume":"363","author":"SJ Collins","year":"2004","unstructured":"Collins SJ, Lawson VA, Masters CL. Transmissible spongiform encephalopathies. Lancet 2004;363:51\u201361.","journal-title":"Lancet"},{"key":"1314_CR3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1054\/jocn.2001.0919","volume":"8","author":"S Collins","year":"2001","unstructured":"Collins S, McLean CA, Masters CL. Gerstmann-Str\u00e4ussler-Scheinker syndrome, fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies. J Clin Neurosci 2001;8:387\u201397.","journal-title":"J Clin Neurosci"},{"key":"1314_CR4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1212\/01.wnl.0000266624.63387.4a","volume":"69","author":"M Noguchi-Shinohara","year":"2007","unstructured":"Noguchi-Shinohara M, Hamaguchi T, Kitamoto T, Sato T, Nakamura Y, Mizusawa H, et al. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease. Neurology 2007;69:360\u20137.","journal-title":"Neurology"},{"issue":"Pt 7","key":"1314_CR5","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1099\/0022-1317-77-7-1601","volume":"77","author":"CI Lasm\u00e9zas","year":"1996","unstructured":"Lasm\u00e9zas CI, Deslys JP, Demaimay R, Adjou KT, Hauw JJ, Dormont D. Strain specific and common pathogenic events in murine models of scrapie and bovine spongiform encephalopathy. J Gen Virol 1996;77(Pt 7):1601\u20139.","journal-title":"J Gen Virol"},{"key":"1314_CR6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0002-9440(10)64705-0","volume":"156","author":"WJ Schulz-Schaeffer","year":"2000","unstructured":"Schulz-Schaeffer WJ, Tsch\u00f6ke S, Kranefuss N, Dr\u00f6se W, Hause-Reitner D, Giese A, et al. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol 2000;156:51\u20136.","journal-title":"Am J Pathol"},{"key":"1314_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2990.2002.00376.x","volume":"28","author":"JR Fraser","year":"2002","unstructured":"Fraser JR. What is the basis of transmissible spongiform encephalopathy induced neurodegeneration and can it be repaired? Neuropathol Appl Neurobiol 2002;28:1\u201311.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1314_CR8","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMoa054625","volume":"355","author":"GW Small","year":"2006","unstructured":"Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, et al. PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med 2006;355:2652\u201363.","journal-title":"N Engl J Med"},{"key":"1314_CR9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B. Ann Neurol 2004;55:306\u201319.","journal-title":"Ann Neurol"},{"key":"1314_CR10","first-page":"584","volume":"12","author":"NP Verhoeff","year":"2004","unstructured":"Verhoeff NP, Wilson AA, Takeshita S, Trop L, Hussey D, Singh K, et al. In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. Am J Geriatr Psychiatry 2004;12:584\u201395.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1314_CR11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1474-4422(08)70001-2","volume":"7","author":"CC Rowe","year":"2008","unstructured":"Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O\u2019Keefe G, et al. Imaging of amyloid beta in Alzheimer\u2019s disease with 18F-BAY94\u20139172, a novel PET tracer: proof of mechanism. Lancet Neurol 2008;7:129\u201335.","journal-title":"Lancet Neurol"},{"key":"1314_CR12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2967\/jnumed.106.037556","volume":"48","author":"Y Kudo","year":"2007","unstructured":"Kudo Y, Okamura N, Furumoto S, Tashiro M, Furukawa K, Maruyama M, et al. 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6-(2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer\u2019s disease patients. J Nucl Med 2007;48:553\u201361.","journal-title":"J Nucl Med"},{"key":"1314_CR13","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1099\/vir.0.19754-0","volume":"85","author":"K Ishikawa","year":"2004","unstructured":"Ishikawa K, Doh-ura K, Kudo Y, Nishida N, Murakami-Kubo I, Ando Y, et al. Amyloid imaging probes are useful for detection of prion plaques and treatment of transmissible spongiform encephalopathies. J Gen Virol 2004;85:1785\u201390.","journal-title":"J Gen Virol"},{"key":"1314_CR14","doi-asserted-by":"crossref","first-page":"8029","DOI":"10.1523\/JNEUROSCI.23-22-08029.2003","volume":"23","author":"M Bresjanac","year":"2003","unstructured":"Bresjanac M, Smid LM, Vovko TD, Petric A, Barrio JR, Popovic M. Molecular-imaging probe 2-(1-[6-[(2-fluoroethyl)(methyl) amino]-2-naphthyl]ethylidene) malononitrile labels prion plaques in vitro. J Neurosci 2003;23:8029\u201333.","journal-title":"J Neurosci"},{"key":"1314_CR15","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/jnen\/63.7.775","volume":"63","author":"M Sadowski","year":"2004","unstructured":"Sadowski M, Pankiewicz J, Scholtzova H, Tsai J, Li Y, Carp RI, et al. Targeting prion amyloid deposits in vivo. J Neuropathol Exp Neurol 2004;63:775\u201384.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1314_CR16","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neulet.2004.08.065","volume":"371","author":"VB Hoefert","year":"2004","unstructured":"Hoefert VB, Aiken JM, McKenzie D, Johnson CJ. Labeling of the scrapie-associated prion protein in vitro and in vivo. Neurosci Lett 2004;371:176\u201380.","journal-title":"Neurosci Lett"},{"key":"1314_CR17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1212\/01.wnl.0000265815.38958.b6","volume":"69","author":"AL Boxer","year":"2007","unstructured":"Boxer AL, Rabinovici GD, Kepe V, Goldman J, Furst AJ, Huang SC, et al. Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease. Neurology 2007;69:283\u201390.","journal-title":"Neurology"},{"key":"1314_CR18","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1136\/jnnp.2008.171496","volume":"80","author":"VL Villemagne","year":"2009","unstructured":"Villemagne VL, McLean CA, Reardon K, Boyd A, Lewis V, Klug G, et al. 11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2009;80:998\u20131001. doi: 10.1136\/jnnp.2008.171496 .","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1314_CR19","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1523\/JNEUROSCI.4456-03.2004","volume":"24","author":"N Okamura","year":"2004","unstructured":"Okamura N, Suemoto T, Shimadzu H, Suzuki M, Shiomitsu T, Akatsu H, et al. Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain. J Neurosci 2004;24:2535\u201341.","journal-title":"J Neurosci"},{"key":"1314_CR20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1471-4159.2006.04035.x","volume":"99","author":"K Ishikawa","year":"2006","unstructured":"Ishikawa K, Kudo Y, Nishida N, Suemoto T, Sawada T, Iwaki T, et al. Styrylbenzoazole derivatives for imaging of prion plaques and treatment of transmissible spongiform encephalopathies. J Neurochem 2006;99:198\u2013205.","journal-title":"J Neurochem"},{"key":"1314_CR21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jns.2009.06.005","volume":"285","author":"M Waragai","year":"2009","unstructured":"Waragai M, Okamura N, Furukawa K, Tashiro M, Furumoto S, Funaki Y, et al. Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease. J Neurol Sci 2009;285:100\u20138. doi: 10.1016\/j.jns.2009.06.005 .","journal-title":"J Neurol Sci"},{"key":"1314_CR22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1447-0594.2007.00430.x","volume":"7","author":"N Okamura","year":"2007","unstructured":"Okamura N, Furumoto S, Funaki Y, Suemoto T, Kato M, Ishikawa Y, et al. Binding and safety profile of novel benzoxazole derivative for in vivo imaging of amyloid deposits in Alzheimer\u2019s disease. Geriatr Gerontol Int 2007;7:393\u2013400.","journal-title":"Geriatr Gerontol Int"},{"key":"1314_CR23","first-page":"47","volume-title":"WHO manual for strengthening diagnosis and surveillance of Creutzfeldt-Jakob disease","author":"M Zeidler","year":"1998","unstructured":"Zeidler M, Gibbs CJ Jr, Meslin F. WHO manual for strengthening diagnosis and surveillance of Creutzfeldt-Jakob disease. Geneva: World Health Organization; 1998. p. 47\u201351."},{"key":"1314_CR24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 1984;34:939\u201344.","journal-title":"Neurology"},{"key":"1314_CR25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hbm.460020402","volume":"2","author":"KJ Friston","year":"1995","unstructured":"Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiack RSJ. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp\u00a01995;2:189\u2013210.","journal-title":"Hum Brain Mapp"},{"key":"1314_CR26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/brain\/104.3.559","volume":"104","author":"CL Masters","year":"1981","unstructured":"Masters CL, Gajdusek DC, Gibbs CJ Jr. Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Str\u00e4ussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain 1981;104:559\u201388.","journal-title":"Brain"},{"key":"1314_CR27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1600-0463.2002.100110.x","volume":"110","author":"JW Ironside","year":"2002","unstructured":"Ironside JW, McCardle L, Horsburgh A, Lim Z, Head MW. Pathological diagnosis of variant Creutzfeldt-Jakob disease. APMIS 2002;110:79\u201387.","journal-title":"APMIS"},{"key":"1314_CR28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(97)24002-X","volume":"349","author":"AF Hill","year":"1997","unstructured":"Hill AF, Zeidler M, Ironside J, Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997;349:99\u2013100.","journal-title":"Lancet"},{"key":"1314_CR29","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1128\/JVI.78.10.4999-5006.2004","volume":"78","author":"K Doh-ura","year":"2004","unstructured":"Doh-ura K, Ishikawa K, Murakami-Kubo I, Sasaki K, Mohri S, Race R, et al. Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models. J Virol 2004;78:4999\u20135006.","journal-title":"J Virol"},{"key":"1314_CR30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1517\/14712598.7.5.713","volume":"7","author":"NG Rainov","year":"2007","unstructured":"Rainov NG, Tsuboi Y, Krolak-Salmon P, Vighetto A, Doh-Ura K. Experimental treatments for human transmissible spongiform encephalopathies: is there a role for pentosan polysulfate? Expert Opin Biol Ther 2007;7:713\u201326.","journal-title":"Expert Opin Biol Ther"},{"key":"1314_CR31","doi-asserted-by":"crossref","first-page":"e1888","DOI":"10.1371\/journal.pone.0001888","volume":"3","author":"A Luigi De","year":"2008","unstructured":"De Luigi A, Colombo L, Diomede L, Capobianco R, Mangieri M, Miccolo C, et al. The efficacy of tetracyclines in peripheral and intracerebral prion infection. PLoS One 2008;3:e1888.","journal-title":"PLoS One"},{"key":"1314_CR32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1871526510909010015","volume":"9","author":"K Teruya","year":"2009","unstructured":"Teruya K, Kawagoe K, Kimura T, Chen CJ, Sakasegawa Y, Doh-ura K. Amyloidophilic compounds for prion diseases. Infect Disord Drug Targets 2009;9:15\u201322.","journal-title":"Infect Disord Drug Targets"},{"key":"1314_CR33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1871526510909010023","volume":"9","author":"G Forloni","year":"2009","unstructured":"Forloni G, Salmona M, Marcon G, Tagliavini F. Tetracyclines and prion infectivity. Infect Disord Drug Targets 2009;9:23\u201330.","journal-title":"Infect Disord Drug Targets"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1314-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-009-1314-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1314-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:01:50Z","timestamp":1558699310000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-009-1314-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,17]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["1314"],"URL":"https:\/\/doi.org\/10.1007\/s00259-009-1314-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,17]]}}}